Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

F.L. Schneiders, R.J. Scheper, B.M.E. von Blomberg, A.M. Woltman, H.L.A. Janssen, A.J.M. van den Eertwegh, H.M.W. Verheul, T.D. de Gruijl, J.J. van der Vliet

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)130-141
JournalClinical Immunology
Issue number2
Publication statusPublished - 2011

Cite this